Tweet
Rev Assoc Med Bras (1992)
. 2023 Nov 13;69(12):e20230616.
doi: 10.1590/1806-9282.20230616. eCollection 2023. Clinical and serological findings in pregnant women and newborns: patterns of coronavirus disease 2019 placental histopathology
Thayana Camara Conde 1 2 , Renato Augusto Moreira de Sá 1 2 , Elyzabeth Avvad Portari 3 , Luis Guillermo Coca Velarde 4 , Luisa Moreira de Ávila 2 , Edward Araujo Júnior 5 6
Affiliations
Objective: The objective of this study was to evaluate the correlation between clinical and serological findings of pregnant women and newborns with patterns of histopathologic changes of the placenta diagnosed with coronavirus disease 2019.
Methods: A prospective descriptive study was conducted with pregnant women who were positive for SARS-CoV-2 by reverse transcription polymerase chain reaction or serology (IgG and IgM). Clinical analyses were performed using ELISA to detect anti-SARS-CoV-2 IgG and IgA antibodies using the S1 spike protein domain with the Euroimmun kit. Histopathologic analyses of placentas were performed by two expert pathologists.
Results: Maternal SARS-CoV-2 infection was associated with increased neonatal hospital length of stay (p=0.03), increased preterm birth (p=0.04), and Apgar score<7 at 1st min (p=0.00) and 5th min (p=0.02). Pregnant women with positive IgG and/or IgA at delivery had a higher incidence of placental histopathologic changes in addition to a greater likelihood of having an IgG-positive fetus (p<0.0001). Placentas with positive reverse transcription polymerase chain reaction for SARS-CoV-2 had a higher incidence of histopathologic changes such as maternal vascular hypoperfusion changes (p=0.00).
Conclusion: Maternal SARS-CoV-2 infection was associated with adverse perinatal outcomes. Pregnant women with positive IgG at delivery had a higher incidence of placental histopathologic changes. Placentas with positive reverse transcription polymerase chain reaction for SARS-CoV-2 had a higher incidence of histopathologic changes such as maternal vascular hypoperfusion.
. 2023 Nov 13;69(12):e20230616.
doi: 10.1590/1806-9282.20230616. eCollection 2023. Clinical and serological findings in pregnant women and newborns: patterns of coronavirus disease 2019 placental histopathology
Thayana Camara Conde 1 2 , Renato Augusto Moreira de Sá 1 2 , Elyzabeth Avvad Portari 3 , Luis Guillermo Coca Velarde 4 , Luisa Moreira de Ávila 2 , Edward Araujo Júnior 5 6
Affiliations
- PMID: 37971121
- PMCID: PMC10645172
- DOI: 10.1590/1806-9282.20230616
Objective: The objective of this study was to evaluate the correlation between clinical and serological findings of pregnant women and newborns with patterns of histopathologic changes of the placenta diagnosed with coronavirus disease 2019.
Methods: A prospective descriptive study was conducted with pregnant women who were positive for SARS-CoV-2 by reverse transcription polymerase chain reaction or serology (IgG and IgM). Clinical analyses were performed using ELISA to detect anti-SARS-CoV-2 IgG and IgA antibodies using the S1 spike protein domain with the Euroimmun kit. Histopathologic analyses of placentas were performed by two expert pathologists.
Results: Maternal SARS-CoV-2 infection was associated with increased neonatal hospital length of stay (p=0.03), increased preterm birth (p=0.04), and Apgar score<7 at 1st min (p=0.00) and 5th min (p=0.02). Pregnant women with positive IgG and/or IgA at delivery had a higher incidence of placental histopathologic changes in addition to a greater likelihood of having an IgG-positive fetus (p<0.0001). Placentas with positive reverse transcription polymerase chain reaction for SARS-CoV-2 had a higher incidence of histopathologic changes such as maternal vascular hypoperfusion changes (p=0.00).
Conclusion: Maternal SARS-CoV-2 infection was associated with adverse perinatal outcomes. Pregnant women with positive IgG at delivery had a higher incidence of placental histopathologic changes. Placentas with positive reverse transcription polymerase chain reaction for SARS-CoV-2 had a higher incidence of histopathologic changes such as maternal vascular hypoperfusion.